-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HFMvNPQFd/geLPv9o1DU2NO5gvB7QxC6x6Dz9umYao5T7doqD+CoOdFp5kvK5kC1 X5hpqmk5IPEbV5NjycbA6A== 0000950135-96-002512.txt : 19960607 0000950135-96-002512.hdr.sgml : 19960607 ACCESSION NUMBER: 0000950135-96-002512 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19960606 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: POLYMEDICA INDUSTRIES INC CENTRAL INDEX KEY: 0000878748 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043033368 STATE OF INCORPORATION: MA FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-43396 FILM NUMBER: 96577325 BUSINESS ADDRESS: STREET 1: 11 STATE ST CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: 6179332020 MAIL ADDRESS: STREET 1: 11 STATE STREET CITY: WOBURN STATE: MA ZIP: 01801 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BIOVENTURE PARTNERS LIMITED PARTNERSHIP CENTRAL INDEX KEY: 0000902158 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 043137773 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 4 MILK ST CITY: PORTLAND STATE: ME ZIP: 04101 BUSINESS PHONE: 2077800904 MAIL ADDRESS: STREET 1: 4 MILK ST CITY: PORTLAND STATE: ME ZIP: 04101 SC 13G/A 1 BIOVENTURE PARTNERS LIMITED PARTNERSHIP 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 3)* Polymedica Industries, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock - -------------------------------------------------------------------------------- (Title of Class of Securities) 731738-10-0 - -------------------------------------------------------------------------------- (CUSIP Number) Check the following box if a fee is being paid with this statement / /. (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7.) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 5 Pages SEC 1745 (2-95) 2 CUSIP NO. 731738-10-0 13G PAGE 2 OF 5 PAGES - -------------------------------------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON BioVenture Partners Limited Partnership 04-3137773 - -------------------------------------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / / (b) /X/ - -------------------------------------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER SHARES 0 BENEFICIALLY ------------------------------------------------------------------------------------------ OWNED BY 6 SHARED VOTING POWER EACH 38,409 (1) REPORTING ------------------------------------------------------------------------------------------ PERSON 7 SOLE DISPOSITIVE POWER WITH 0 ------------------------------------------------------------------------------------------ 8 SHARED DISPOSITIVE POWER 38,409 (1) - --------------------------------------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 38,409(1) - -------------------------------------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - -------------------------------------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 .51% - -------------------------------------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* PN - -------------------------------------------------------------------------------------------------------------- (1) Beneficial Ownership of all but 3,409 shares is expressly disclaimed.
*SEE INSTRUCTION BEFORE FILLING OUT! Page 2 of 5 pages 3 Page 3 of 5 ----------- SCHEDULE 13G ------------ ITEM 1. - ------ (a) Name of Issuer: PolyMedica Industries, Inc. (b) Address of Issuer's Principal Executive Offices: 11 State Street Woburn, MA 01801 ITEM 2. - ------ (a) Name of Person Filing: BioVenture Partners Limited Partnership (b) Address of Principal Business Office or, if none, Residence: 4 Milk Street Portland, ME 04101 (c) Citizenship: Delaware (d) Title of Class of Securities: Common (e) CUSIP Number: 731738-10-0 ITEM 3. Persons filing pursuant to Rule 13d-1(b) or 13d-2(b): - ------ N/A 4 Page 4 of 5 ----------- ITEM 4. Ownership: - ------ (a) Amount beneficially owned: 3,409 shares directly and 35,000 shares by a limited partnership of which the reporting person is the general partner. The 35,000 shares are expressly disclaimed. (b) Percent of Class: .51% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: 3,409 (ii) Shared power to vote or to direct the vote: 35,000 (iii) Sole power to dispose or to direct the disposition of: 3,409 (iv) Shared power to dispose or to direct the disposition of: 35,000 ITEM 5. Ownership of Five Percent or Less of a Class: - ------ If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X]. ITEM 6. Ownership of More than Five Percent on Behalf of Another Person: - ------ N/A ITEM 7. Identification and Classification of the Subsidiary Which - ------ Acquired the Security Being Reported on By the Parent Holding Company: N/A ITEM 8. Identification and Classification of Members of the Group: - ------ N/A ITEM 9. Notice of Dissolution of Group: - ------ N/A 5 Page 5 of 5 ----------- ITEM 10. Certification: - ------- N/A SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. BIOVENTURE PARTNERS LIMITED PARTNERSHIP By Commonwealth BioVentures Inc., its General Partner Date: May ___, 1996 By: _____________________________________ Robert G. Foster, President -----END PRIVACY-ENHANCED MESSAGE-----